NDC 68462-371 – Topiramate
Topiramate 200 mg/1 · Capsule, Extended Release · Oral
Product NDC68462-371
Product details
- Brand name
- Topiramate
- Generic name
- Topiramate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA210278
- Marketed since
- February 1, 2021
- Listing expires
- December 31, 2027
Active ingredients
- Topiramate 200 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 68462-371-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-05) | Feb 1, 2021 |
| 68462-371-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-30) | Feb 1, 2021 |
| 68462-371-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-90) | Feb 1, 2021 |
Other Topiramate products
- 27241-297 Topiramate 50 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-300 Topiramate 200 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-299 Topiramate 150 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-298 Topiramate 100 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-228 Topiramate 50 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-230 Topiramate 200 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-229 Topiramate 100 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-227 Topiramate 25 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 27241-296 Topiramate 25 mg/1 · Capsule, Extended Release · Ajanta Pharma USA Inc.
- 42291-955 Topiramate 25 mg/1 · Capsule, Extended Release · AvKARE
- 42291-956 Topiramate 50 mg/1 · Capsule, Extended Release · AvKARE
- 42291-957 Topiramate 100 mg/1 · Capsule, Extended Release · AvKARE